Head to Head Analysis: Autonomix Medical (AMIX) and The Competition

Autonomix Medical (NASDAQ:AMIX) is one of 236 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Autonomix Medical to related businesses based on the strength of its analyst recommendations, earnings, valuation, risk, profitability, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Autonomix Medical and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1916	4912	9153	268	2.48

Autonomix Medical currently has a consensus target price of $28.00, indicating a potential upside of 410.02%. As a group, “Surgical & medical instruments” companies have a potential upside of 15.30%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Autonomix Medical is more favorable than its competitors.

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 47.9% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 15.6% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Autonomix Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.62%	-156.70%	-27.31%

Earnings & Valuation

This table compares Autonomix Medical and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.34
Autonomix Medical Competitors	$1.02 billion	$10.48 million	-6.94

Autonomix Medical’s competitors have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Autonomix Medical Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.